Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
The Zacks Analyst Blog Highlights Merck, Thermo Fisher Scientific, American Express, Valero Energy and Weyerhaeuser
01:28pm, Thursday, 16'th Feb 2023 Zacks Investment Research
Merck, Thermo Fisher Scientific, American Express, Valero Energy and Weyerhaeuser are part of the Zacks top Analyst Blog.
2 Market-Beating Dividend Stocks to Buy With $500
12:45pm, Thursday, 16'th Feb 2023 The Motley Fool
These two leading healthcare stocks have been rewarding shareholders with dividends for a while.
2 Market-Beating Dividend Stocks to Buy With $500
07:45am, Thursday, 16'th Feb 2023
These two leading healthcare stocks have been rewarding shareholders with dividends for a while.
Competition Coming For AbbVie's Blockbuster Humira
01:08am, Thursday, 16'th Feb 2023
It's among the prohibitively expensive biologic pharmaceuticals being replaced by cheaper “biosimilar” copycats. Relief is on the way for patients who need Humira, a product made by AbbVie.
Top Stock Reports for Merck, Thermo Fisher Scientific & American Express
09:59pm, Wednesday, 15'th Feb 2023 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc. (MRK), Thermo Fisher Scientific Inc. (TMO) and American Express Company (AXP).
Robinhood, Merck And 2 Other Stocks Insiders Are Selling
01:03pm, Wednesday, 15'th Feb 2023 Benzinga
The Nasdaq closed higher by around 0.6% on Tuesday, also recording losses for the week. Investors, meanwhile, focused on some notable insider trades.
When insiders sell shares, it indicates their conc
Why Top Ships Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
07:26pm, Tuesday, 14'th Feb 2023 Benzinga
Gainers
Amesite Inc. (NASDAQ: AMST) shares jumped 123% to $0.6284 after the company announced GPT-3 powered functionality to its AI toolkit for customers and users.
Boxlight Corporation (NASDAQ: BOXL
4 Factor Dividend Growth Portfolio - January 2023 Update
06:48pm, Tuesday, 14'th Feb 2023
The 4 factor dividend growth portfolio was launched on November 1st, 2022, and is thus far off to a great start. The portfolio lost by 11 bps to the S&P 500 Total Return during the month of January.
Stellar Opportunity For Merck At Upcoming Data Presentation, Analyst Says While Boosting Price Target
05:51pm, Monday, 13'th Feb 2023 Benzinga
Credit Suisse has raised the price target on Merck & Co Inc (NYSE: MRK) from $120 to $125, with an Outperform rating.
The 2023 American College of Cardiology conference is expected to be a signifi
Fox, MGM Resorts And 3 Other Stocks Insiders Are Selling
12:57pm, Monday, 13'th Feb 2023 Benzinga
The Nasdaq closed lower on Friday, also recording losses for the week. Investors, meanwhile, focused on some notable insider trades.
When insiders sell shares, it indicates their concern in the compan
2 Blue Chip Stocks To Watch For February 2023
02:09pm, Saturday, 11'th Feb 2023
Two top blue chip stocks to watch in the stock market right now.
Final Trades: XRT, PEP & MRK
06:08pm, Friday, 10'th Feb 2023
The final trades of the week. With CNBC's Melissa Lee and the Fast Money traders, Tim Seymour, Courtney Garcia and Jeff Mills.
Capital Wealth Planning's Kevin Simpson's five-star plays
05:33pm, Friday, 10'th Feb 2023
Kevin Simpson, Capital Wealth Planning founder, joins 'Closing Bell: Overtime' to discuss his five-star stock strategies.
Pharmaceutical companies losing patent protection as competition grows
03:34pm, Thursday, 09'th Feb 2023
The Wall Street Journal's Jared Hopkins joins 'Power Lunch' to discuss biotech patent protection duration, competition coming to the pharmaceutical industry and pharmaceutical M&A plans.
Amazon, Tesla And 2 Other Stocks Insiders Are Selling
01:56pm, Thursday, 09'th Feb 2023 Benzinga
The Nasdaq dropped by around 200 points on Wednesday. Investors, meanwhile, focused on some notable insider trades.
When insiders sell shares, it indicates their concern in the company’s prospects o
